Notably, treatment with REGN5093-M114 showed favorable responses in TKI-naïve EGFR-mutant NSCLC cells with c-MET overexpression, irrespective of MET gene copy number (111). This evidence concerns the gene EGFR and non-small cell lung carcinoma.